Magnetic resonance in the study of the small bowel;La risonanza magnetica nello studio del piccolo intestino

Radiologia Medica

Volumn 106, Issue 1-2, 2003, Pages 1-17

  Laghi, Andrea ^a   Passariello, Roberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

MR, enteroclysis; MR, oral contrast agents; MR, small bowel

Indexed keywords

BARIUM SULFATE; CONTRAST MEDIUM; ENEMA; FERROUS ION; GADOLINIUM CHELATE; IRON OXIDE; MACROGOL 4000; MANGANESE; MANNITOL; METHYLCELLULOSE; PERFLUOROOCTYL BROMIDE; SCOPOLAMINE BUTYL BROMIDE; SPASMOLYTIC AGENT; WATER;

ABDOMINAL CRAMP; AQUEOUS SOLUTION; ARTICLE; CELIAC DISEASE; CHRONIC INFLAMMATION; CLINICAL PRACTICE; CONTRAST ENHANCEMENT; CROHN DISEASE; DIARRHEA; HUMAN; HYPEROSMOLARITY; MALABSORPTION; MEDICAL RESEARCH; METEORISM; METHODOLOGY; NASOGASTRIC TUBE; NUCLEAR MAGNETIC RESONANCE IMAGING; SIGNAL NOISE RATIO; SMALL INTESTINE; SMALL INTESTINE TUMOR; TECHNOLOGY; VOMITING;

ADMINISTRATION, ORAL; CONTRAST MEDIA; HUMANS; INTESTINAL DISEASES; INTESTINE, SMALL; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY;

EID: 0141886315     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Runge VM, Foster MA, Clanton JA et al: Particulate oral NMR contrast agents. Int J Nucl Med Biol 12: 37-42, 1985.
2. Wesbey GE, Brasch RC, Goldberg HI et al: Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging; initial clinical experience. Magn Reson Imaging 3: 57-64, 1985.
3. Hahn PF, Stark DD, Saini S et al: Ferrite particles for bowel contrast in MR imaging: design issues and feasibility studies. Radiology 164: 37-41, 1987.
4. Widder DJ, Edelman RR, Grief WL et al: Magnetite albumin suspension: a superparamagnetic oral MR contrast agent. AJR 149: 839-843, 1987.
5. Laniado M, Kornmesser W, Hamm B et al: MR imaging of the gastrointestinal tract: value of Gd-DTPA. AJR 150: 817-821, 1988.
6. Bisset GS: 3rd. Evaluation of potential practical oral contrast agents for pediatric magnetic resonance imaging. Preliminary observations. Pediatr Radiol 20: 61-66, 1989.
7. Lonnemark M, Hemmingsson A, Bach-Gansmo T: Effect of superparamagnetic particles as oral contrast medium at magnetic resonance imaging. A phase I clinical study. Acta Radiol 30: 193-196, 1989.
8. Li KC, Ang PG, Tart RP et al: Paramagnetic oil emulsions as oral magnetic resonance imaging contrast agents. Magn Reson Imaging 8: 589-598, 1990.
9. Hahn PF, Stark DD, Lewis JM: First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology 175: 695-700, 1990.
10. Tart RP, Li KC, Storm BL et al: Enteric MRI contrast agents: comparative study of five potential agents in humans. Magn Reson Imaging 9: 559-568, 1991.
11. Rubin DL, Muller HH, Young SW: Methods for the systematic investigation of gastrointestinal contrast media for MRI: evaluation of intestinal distribution by radiographic monitoring. Magn Reson Imaging 9: 285-293, 1991.
12. Li KC, Tart RP, Fitzsimmons JR et al: Barium sulphate suspension as a negative oral MRI contrast agent: in vitro and human optimization studies. Magn Reson Imaging 9: 141-150, 1991.
13. Ros PR, Steinman RM, Torres GM et al: The value of barium as a gastrointestinal contrast agent in MR imaging: a comparison study in normal volunteers. AJR Am J Roentgenol 157: 761-767, 1991.
14. Patten RM, Moss AA, Fenton TA et al: OMR, a positive bowel contrast agent for abdominal and pelvic MR imaging: safety and imaging characteristics. J Magn Reson Imaging 2: 25-34, 1992.
15. Van Beers B, Grandin C, Jamart J et al: Magnetic resonance imaging of lower abdominal and pelvic lesions: assessment of oral magnetic particles as an intestinal contrast agent. Eur J Radiol 14: 252-257, 1992.
16. Mirowitz SA, Susman N: Use of nutritional support formula as a gastrointestinal contrast agent for MRI. J Comput Assist Tomogr 16: 908-915, 1992.
17. Chou CK, Liu GC, Chen LT et al: The use of MRI in bowel obstruction. Abdom Imaging. 18: 131-135, 1993.
18. Hirohashi S, Uchida H, Yoshikawa K et al: Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI. Magn Reson Imaging 12: 837-846, 1994.
19. Anderson CM, Brown JJ, Baffe DM: MR imaging of Crohn disease: use of perflubron as a gastrointestinal contrast agent. J Magn Reson Imaging 4: 491-496 1994.
20. Bernardino ME, Weinreb JC, Mitchell DG et al: Safety and optimum concentration of a manganese chloride-based oral MR contrast agent. J Magn Reson Imaging 4: 872-876, 1994.
21. Haldemann Heusler RC, Wight E, Marincek B: Oral superparamagnetic contrast agent (ferumoxsil): tolerance and efficacy in MR imaging of gynecologic diseases. J Magn Reson Imaging. 5: 385-391, 1995.
22. Rollandi GA, Martinoli C, Conzi R et al: Magnetic resonance imaging of the small intestine and colon in Crohn's disease. Radiol Med 91: 81-85, 1996.
23. Van Beers BE, Grandin C, De Greef D et al: Ferristene as intestinal MR contrast agent. Distribution and safety of a fast ingestion procedure with oral metoclopramide. Acta Radiol 37: 676-679, 1996.
24. Semelka RC, John G, Kelekis NL et al: Small bowel neoplastic disease: demonstration by MRI. J Magn Reson Imaging 6: 855-860, 1996.
25. Madsen SM, Thomsen HS, Munkholm P et al: Magnetic resonance imaging of Crohn disease: early recognition of treatment response and relapse. Abdom Imaging 22: 164-166, 1997.
26. Faber SC, Stehling MK, Holzknecht N et al: Pathologic conditions in the small bowel: findings at fat-suppressed gadolinium-enhanced MR imaging with an optimized suspension of oral magnetic particles. Radiology 205: 278-282, 1997.
27. Aschoff AJ, Zeitler H, Merkle EM et al: MR enteroclysis for nuclear spin tomographic diagnosis of inflammatory bowel diseases with contrast enhancement. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 167: 387-391, 1997.
28. Paley MR, Ros PR: MRI of the gastrointestinal tract. Eur Radiol 7: 1387-1397, 1997.
29. Ernst O, Asselah T, Cablan X et al: Breath-hold fast spin-echo MR imaging of Crohn's disease. AJR Am J Roentgenol 170: 127-128, 1998.
30. Rieber A, Wruk D, Nussle K et al: MRI of the abdomen combined with enteroclysis in Crohn disease using oral and intravenous Gd-DTPA. Radiologe 38: 23-28, 1998.
31. Holzknecht N, Helmberger T, von Ritter C et al: MRI of the small intestine with rapid MRI sequences in Crohn disease after enteroclysis with oral iron particles. Radiologe 38: 29-36, 1998.
32. Ha HK, Lee EH, Lim CH et al: Application of MRI for small intestinal diseases. J Magn Reson Imaging 8: 375-383, 1998.
33. Lee JK, Marcos HB, Semelka RC: MR imaging of the small bowel using the HASTE sequence. AJR Am J Roentgenol 170: 1457-1463, 1998.
34. Regan F, Beall DP, Bohlman ME et al: Fast MR imaging and the detection of small-bowel obstruction. AJR Am J Roentgenol 170: 1465-1469, 1998.
35. Adamek HE, Breer H, Karschkes T et al: Magnetic resonance imaging in gastroenterology: time to say good-bye to all that endoscopy? Endoscopy 32: 406-410, 2000.
36. Marcos HB, Semelka RC: Evaluation of Crohn's disease using half-fourier RARE and gadolinium-enhanced SGE sequences: initial results. Magn Reson Imaging 18: 263-268, 2000.
37. Durno CA, Sherman P, Williams T et al: Magnetic resonance imaging to distinguish the type and severity of pediatric inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 30: 170-174, 2000.
38. Maccioni F, Viscido A, Broglia L et al: Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 25: 219-228, 2000.
39. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J et al: MR enteroclysis protocol optimization: comparison between 3D FLASH with fat saturation after intravenous gadolinium injection and true FISP sequences. Eur Radiol 11: 908-913, 2001.
40. Rofsky NM, Lee VS, Laub G et al: Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 212: 876-884, 1999.
41. Sodickson DK, Manning WJ: Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays. Magn Reson Med 38: 591-603, 1997.
42. Lomas DJ: Techniques for magnetic resonance imaging of the bowel. Topics in MRI 13: 379-388, 2002.
43. Roemer PB, Edelstein WA, Hayes CE et al: The NMR phased array. Magn Reson Med 16:192-225, 1990.
44. Barkhausen J, Quick HH, Lauenstein T et al: Whole-body MR imaging in 30 seconds with real-time true FISP and a continuously rolling table platform: feasibility study. Radiology 220: 252-256, 2001.
45. Beall DP, Fortman BJ, Lawler BC et al: Imaging bowel obstruction: a comparison between fast magnetic resonance imaging and helical computed tomography. Clin Radiol 57: 719-724, 2002.
46. Debatin JF, Patak MA: MRI of the small and large bowel. Eur Radiol 9: 1523-1534, 1999.
47. Rieber A, Nussle K, Reinshagen M et al: MRI of the abdomen with positive oral contrast agents for the diagnosis of inflammatory small bowel disease. Abdom Imaging. 27: 394-399, 2002.
48. Malcolm PN, Brown JJ, Hahn PF et al: The clinical value of ferric ammonium citrate: a positive oral contrast agent for TI-weighted MR imaging of the upper abdomen. J Magn Reson Imaging 12: 702-707, 2000.
49. Laghi A, Paolantonio P, Iafrate F et al: Oral contrast agent for MRI of the bowel. Topics in MRI 13: 389-396, 2002.
50. Lomas DJ, Graves MJ: Small bowel MRI using water as a contrast medium. Br J Radiol 72: 994-997, 1999.
51. Minowa O, Ozaki Y, Kyogoku S et al: MR imaging of the small bowel using water as a contrast agent in a preliminary study with healthy volunteers. AJR Am J Roentgenol 173: 581-582, 1999.
52. Schunk K: Small bowel magnetic resonance imaging for inflammatory bowel disease. Topics in MRI, 13: 409-426, 2002.
53. Sood RR, Joubert I, Franklin H et al: Small bowel MRI: comparison of a polyethylene glycol preparation and water as oral contrast media. J Magn Reson Imaging 15: 401-408, 2002.
54. Laghi A, Carbone I, Catalano C et al: Polyethylene glycol solution as an oral contrast agent for MR imaging of the small bowel. AJR Am J Roentgenol 177: 1333-1334, 2001.
55. Patak MA, Froehlich JM, von Weymarn C et al: Non-invasive distension of the small bowel for magnetic-resonance imaging. Lancet 358: 987-988, 2001.
56. Schunk K, Kern A, Oberholzer K et al: Hydro-MRI in Crohn's disease: appraisal of disease activity. Invest Radiol 35: 431-437, 2000.
57. Laghi A, Borrelli O, Paolantonio P et al: Contrast-enhanced magnetic resonance imaging of the terminal ileum in children with Crohn's disease. GUT 52: 393-397, 2002.
58. D'Arienzo A, Scaglione G, Bennato R et al: The prognostic value, in active ulcerative colitis, of an increased intensity of colonic perivisceral fat signal on magnetic resonance imaging with ferumoxil. Am J Gastroenterol 96: 481-486, 2001.
59. Umschaden HW, Szolar D, Gasser J et al: Small-bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology 215: 717-725, 2000.
60. Maglinte DD, Siegelman ES, Kelvin FM et al: MR enteroclysis: the future of small-bowel imaging? Radiology 215: 639-641, 2000.
61. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J et al: MR enteroclysis: technical considerations and clinical applications. Eur Radiol. 12: 2651-2682, 2002.
62. Rieber A, Aschoff A, Nussle K et al: MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol 10: 1377-1382, 2000
63. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J et al: MR imaging of the small bowel with a true-FISP sequence after enteroclysis with water solution. Invest Radiol. 35: 707-711 2000.
64. Papanikolaou N, Prassopoulos P, Grammatikakis J et al: Optimization of a contrast medium suitable for conventional enteroclysis, MR enteroclysis, and virtual MR enteroscopy. Abdom Imaging 27: 517-522, 2002.
65. Prassopoulos P, Papanikolaou N, Grammatikakis J et al: MR enteroclysis imaging of Crohn disease. RadioGraphics 21: 161-172, 2001.
66. Rieber A, Wruk D, Potthast S et al: Diagnostic imaging in Crohn's disease: comparison of magnetic resonance imaging and conventional imaging methods. Int J Colorectal Dis 15: 176-181, 2000.
67. Madsen SM, Thomsen HS, Schlichting P et al: Evaluation of treatment response in active Crohn's disease by low-field magnetic resonance imaging. Abdom Imaging 24: 232-239, 1999.
68. Shoenut JP, Semelka RC, Magro CM et al: Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol 19: 31-35, 1994.
69. Low RN, Sebrechts CP, Politoske DA et al: Crohn disease with endoscopic correlation: single-shot fast spin-echo and gadolinium-enhanced fat-suppressed spoiled gradient-echo MR imaging. Radiology 222: 652-660, 2002.
70. Koh DM, Miao Y, Chinn RJ et al: MR imaging evaluation of the activity of Crohn's disease. Am J Roentgenol 177: 1325-1332, 2001.
71. Laghi A, Paolantonio P, Catalano C et al: MR Imaging of the Small Bowel Using Polyethylene Glycol Solution as an Oral Contrast Agent in Adults and Children with Celiac Disease: Preliminary Observations. Am J Roentgenol 180: 191-194, 2003.